![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Jubilant Pharmova Limited Nanjangud In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Paroxetine hydrochloride hemihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-204 - Rev 02
This Chemical Type CEP, issued on August 23, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2018 associated with this CEP further emphasizes